Bengt Dahlström, founder of the Center for Translational Research, has handed over the gavel to Hans Andreasson after seven years as chairman of the group. The decision was taken at the Annual General Meeting on May 23.
"Renewal and continuity have always been important keywords to strengthen the board of CTR. It is therefore with pleasure and confidence that I hand over the chairmanship to Hans Andreasson" says Bengt Dahlström in a press release.
The newly appointed Chairman of the Board, Hans Andreasson, has been a member of CTR's Board of Directors since 2020, and already has extensive experience from leading positions in the life science sector and from international board work. He is currently Investment Director at the Sixth AP Fund.
The AGM also elected Katarina Sjögren as a new board member. She has extensive experience from various management assignments in companies in healthcare, care and education, and was most recently CEO of the education company Atvexa.
Read the full press release here